Table of Contents
Afrezza is a groundbreaking inhalable insulin used to help manage blood glucose levels in people with diabetes. Unlike traditional injectable insulins, Afrezza offers a rapid-acting alternative that begins working within minutes, providing more flexibility and control for users.
How Afrezza Works in the Body
Afrezza contains human insulin that is delivered directly to the lungs through inhalation. Once inhaled, the insulin quickly enters the bloodstream, mimicking the body’s natural response to food intake. This rapid absorption helps lower blood sugar levels effectively during meals.
Mechanism of Action
The insulin particles in Afrezza are designed to be ultra-rapid, beginning to work within about 12-15 minutes after inhalation. Peak action occurs around 53 minutes, and the effects typically last 2-3 hours. This quick onset helps prevent post-meal blood sugar spikes.
Advantages of Rapid-Acting Insulin
- Fast action: Reduces the time between insulin administration and blood sugar reduction.
- Flexibility: Easier to coordinate with meals and activity.
- Reduced risk of hypoglycemia: Shorter duration minimizes the chance of low blood sugar episodes.
Comparison with Traditional Insulin
Traditional rapid-acting insulins, like insulin lispro or aspart, are usually injected subcutaneously and may take 30 minutes to start working. In contrast, Afrezza’s inhalable form begins acting much faster, offering improved timing for mealtime glucose control.
Safety and Considerations
While Afrezza provides many benefits, it is not suitable for everyone. Patients with lung diseases like asthma or COPD should avoid inhaled insulin. Healthcare providers will evaluate lung function before prescribing Afrezza to ensure safety.
Possible Side Effects
Common side effects include cough, throat irritation, and mild hypoglycemia. Rarely, lung function may decline, so regular monitoring is essential during treatment.
Conclusion
Afrezza represents a significant advancement in insulin therapy, offering rapid action and convenience for people managing diabetes. Its unique delivery method and quick onset make it a valuable option, especially for those seeking more flexible glucose control. As always, patients should consult their healthcare providers to determine if inhaled insulin is appropriate for their needs.